[1]
A. M., H.V. and NAMBOORI, P.K.K. 2022. DESIGN AND DEVELOPMENT OF A PHARMACOGENOMIC MODEL FOR BREAST CANCER TO STUDY THE VARIATION IN DRUG ACTION AND SIDE EFFECTS. International Journal of Applied Pharmaceutics. 14, 3 (May 2022), 61–68. DOI:https://doi.org/10.22159/ijap.2022v14i3.44356.